| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.009 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.009 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |